Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-10

Clinical Trial Update: Psilocybin-assisted Therapy for Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating psilocybin-assisted therapy for alcohol use disorder is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: University of Sydney | Conditions: Alcohol Use Disorder, Alcohol Dependence | Phase 2 | Status: NOT_YET_RECRUITING